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1. Introduction 
Traumatic brain injury (TBI) is a spectrum of pathological changes in the brain that result 
from application of external mechanical force(s) leading to temporary or permanent 
impairment of neurological function. TBI is a global health problem. In 1990, 9.5 million 
individuals worldwide sustained a TBI severe enough to warrant medical attention or result 
in death (Corrigan, Selassie, & Orman 2010). In the United States, the annual incidence of 
TBI is 506.4 per 100,000 population (Langlois JA 2006), in Europe it is 235 per 100,000 
population (Tagliaferri et al. 2006), and in Asia it is reported to range from 160 (Gururaj G 
2004) to 344 (Chiu et al. 1997) per 100,000 population (incidence rate from United States is 
inclusive of emergency department visits, hospital discharges and deaths, incidence rates 
from Europe and Asia are inclusive of hospital discharges and deaths only). Severe TBI has 
long term consequences for the individual and the society. In the United States, it is 
estimated that annually 43.1% (124,000) of the individuals discharged after acute 
hospitalization for TBI (Selassie et al. 2008) develop long term disability. The prevalence of 
individuals in the United States with disability secondary to TBI is estimated to be 3.2 
million (Zaloshnja et al. 2008). The total life time cost of treating TBI cases in the United 
States, including loss of productivity, is estimated to be $ 60.4 billion for the year 2000 
(Corrigan, Selassie, & Orman 2010).The enormous economic and social burden imposed by 
TBI demands aggressive measures to prevent and treat TBI.  
Technological developments and better understanding of brain physiology have resulted in 
a dramatic improvement in mortality related to TBI. Mortality rates declined precipitously 
between 1970 and 1990, likely related to the routine use of computed tomography (CT) scans 
and intracranial pressure (ICP) monitoring, as well as improvement in trauma resuscitation 
generally. However, despite more recent advances in neuromonitoring and neuroimaging, 
mortality has remained steady at approximately 35% since the 1990s (Stein et al. 2010). The 
reasons for this lack of progress are multifactorial; no doubt the increase in severe TBI 
among the elderly is a contributing factor (Colantonio et al. 2008). Nevertheless, the field of 
neurotrauma has suffered from the lack of well organized multicenter, randomized clinical 
trials designed to assess the efficacy of the newer techniques and interventions for the 
management of TBI. Efforts to design and conduct clinical trials in TBI have been 
challenging for many reasons including the heterogeneity of the disease, barriers to 
recruitment, and lack of standardized management protocols across centers (Narayan et al. 
2002). This chapter presents an overview of the pathophysiology and basic principals of 
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2. Mechanism  
TBI results from the application of external force to cranium and its contents. The severity of 
injury is determined by the nature, magnitude and duration of load applied to cranium and 
the force vector (rotational, translational or angular) (Gennarelli 1993). Force applied to 
cranium can be static (delivered over more than 200 milliseconds) or dynamic (delivered 
over less than 200 milliseconds). Static loading is a less common cause of TBI in clinical 
situations, and usually leads to focal brain damage. Dynamic loading is a more common 
cause of TBI, and produces more complex and widespread brain damage. Dynamic loading 
itself results from direct blow to the cranium (contact load), or rapid acceleration or 
deceleration of the cranium (inertial load) that causes differential motion of the brain 
relative to the skull. Inertial loading can cause translational movement (linear motion of 
brain in the skull), rotational movement (shearing motion of different layers of brain in 
relation to one another), and angular movement (a combination of translational and 
rotational movements). In most clinical situations, severe TBI is initiated by impact to the 
head of a solid object at a high velocity, leading to brain damage by a combination of contact 
and inertial loading (Graham, Adams, & Gennarelli 1988). 
Traumatic brain injury can be focal or diffuse. Focal injury manifests as fractures, contusion or 
hematoma with mass effect. Contact loading, wherein a significant force is applied to cranium, 
can cause fracture at the site of impact with underlying contusion or epidural/subdural 
hematoma. If contact loading also produces translational acceleration or deceleration of the 
brain within the cranium, it can also cause focal damage by compression of brain under the 
site of impact (coup contusion) or remote from it (counter coup contusion). Diffuse brain 
injury results from rotational or angular acceleration or deceleration of the brain; the 
presentation can vary from transient loss of consciousness (concussion) to diffuse axonal injury 
(DAI) with prolonged coma. With increasing magnitude of inertial force progressively deeper 
structures in the brain suffer DAI (Adams et al. 1989).  In clinical situations focal lesions and 
DAI frequently coexist (Skandsen et al. 2010). 
3. Pathophysiology 
TBI is not a static event, but a constantly evolving dynamic process. The initial insult leads 
to instant brain damage known as primary brain injury. Primary brain injury triggers a 
cascade of events that cause brain edema, intracranial hypertension, and consequent 
ischemia, categorized as secondary brain damage (Enriquez & Bullock 2004). In diffuse 
injury the primary insult is at the cellular level and initiates events that lead to release of 
excitatory neurotransmitters, loss of ionic homeostasis, disruption of ATP production, 
toxicity from free radical production, loss of auto regulation and breakdown of blood brain 
barrier (BBB). These pathological changes lead to secondary injury. Similar secondary 
changes also occur in the region surrounding an area of contusion or traumatic hematoma, 
with a zone of ischemia and swelling developing around the focal injury. Tissue in this 
“ischemic penumbra” is at risk of dying but also salvageable (Schroder et al. 1995; Leker & 
Shohami 2002). Treatment of acute TBI is directed at minimizing secondary brain damage 
that follows focal as well as diffuse TBI. 
A good understanding of cellular and biochemical changes that follow brain trauma is 
required for the optimal management of brain injury, and for directing future research 
aimed at design of new therapies and protocols. A detailed discussion of these changes is 
www.intechopen.com
 
Traumatic Brain Injury – Acute Care 
 
357 
beyond the scope of this chapter; however, a brief summary is presented. Following trauma, 
the excitatory amino acid glutamate is released from the presynaptic neurons and activates 
both post synaptic neurons and glial cells. Under physiological conditions both glial cells 
and postsynaptic neurons actively remove glutamate from the synaptic space. Following 
trauma the high levels of glutamate activate receptors in the cell membranes of postsynaptic 
neurons and glial cells, resulting in Ca2+ influx into the cell with consequent free radical 
formation and increased oxidative stress. Calcium ions also accumulate in the mitochondria 
leading to mitochondrial membrane damage and disruption of energy cycle. These events 
eventually trigger necrosis and apoptosis in the cells (Enriquez & Bullock 2004; Shohami et 
al. 1997). 
TBI disrupts the BBB that allows fluid to move from intravascular compartment to 
extravascular compartment in the brain with resultant brain swelling and intracranial 
hypertension, which in turn leads to fall in cerebral perfusion thus further exacerbating 
brain ischemia. Aquaporins, matrix metalloproteinases and vasoactive inflammatory agents 
are potential mediators of BBB breakdown following trauma (Donkin & Vink 2010). A 
porous BBB allows infiltration of inflammatory cells into damaged brain. These cells 
(neutrophils and macrophages) release free radicals and cytokines into the brain tissue 
accentuating the damage (Soares et al. 1995).  
4. Initial management at the scene of injury 
Pre-hospital management is a critical step in the overall care of acute brain injury. Early 
institution of optimal care will minimize secondary injury while the patient is transported to 
a tertiary care facility. About half the deaths following TBI occur within first 2 hours of the 
injury (Badjatia, Carney et al. 2008) thereby signifying the importance of optimal pre-
hospital care. 
Pillars of pre-hospital care are restoring and maintaining airway, breathing and circulation 
(ABC) (Dewall 2010). The cervical spine must be immobilized as the patient is resuscitated, 
and spine precautions should be maintained till the patient is transferred to a trauma center. 
Intubation is indicated to secure the airway if the Glasgow Coma Scale (GCS) is less than 9, 
if the patient is hypoxic (SpO2 < 90%) despite supplemental oxygen, or if the patient is 
unable to maintain a patent airway (Gabriel et al. 2002). The SpO2 should be kept above 
95%, while maintaining eucapnea with an end tidal carbon dioxide (EtCO2) of 35 to 40 mm 
Hg (Badjatia, Carney et al. 2008). Hypotension accelerates secondary injury, and must be 
promptly recognized and treated. Systolic blood pressure below 90 mm Hg has been shown 
to increase mortality by two fold in TBI (Chesnut et al. 1993). Intravenous access should be 
promptly established, and normal saline is a reasonable choice for pre hospital fluid 
resuscitation (Dewall 2010). Intravenous dextrose should be administered only if blood 
glucose is less than 70 mg/dl (Badjatia, Carney et al. 2008). Persistent hypotension should 
prompt search for extracranial injury or spinal cord injury. Neurogenic hypotension 
presents with bradycardia and hypotension as opposed to hypovolemic shock that is 
characterized by tachycardia and hypotension. 
Glasgow coma scale (GCS) and pupillary response should be documented after the ABCs of 
resuscitation are complete, and if more than one provider is available, this can be done 
while the ABCs are being secured. Assessment of the GCS and pupillary response in pre-
hospital setting allows the emergency medical personnel to communicate to the receiving 
hospital the neurological status of the patient, screen for cerebral herniation and trend the 
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neurological status (Badjatia, Carney et al. 2008). A quick secondary survey for extracranial 
injuries should be performed prior to transport (Dewall 2010). 
Timely transport of these patients to tertiary care center is critical to a favorable outcome. 
Patients with severe TBI (GCS < 9) should be transported directly to a facility equipped with 
an immediately available CT scanner, prompt neurosurgical care and the ability to monitor 
intracranial pressure and treat intracranial hypertension (Badjatia, Carney et al. 2008), even 
if it is not the closest hospital (Hartl et al. 2006). Mortality can increase by 50%, if a severe 
TBI patient is not directly transported to such a facility (Hartl et al. 2006). Mode of transport 
(by road or air) should be chosen to minimize the transit time (Dewall 2010), as mortality 
following acute subdural hematoma has been shown to be directly linked to time to surgical 
intervention (Seelig et al. 1981). 
5. Medical management 
5.1 Principles of intensive care 
Management of the patient with traumatic brain injury is directed predominantly at 
minimizing and preventing secondary brain injury, which can result from intracranial or 
systemic causes. Although the mechanisms of secondary brain injury are incompletely 
understood, inadequate cerebral perfusion and oxygenation are integral factors. Systemic 
hypoxia and hypotension are significantly associated with increased morbidity and 
mortality. This effect was demonstrated in a data set from the Traumatic Coma Data Bank, 
in which a single episode of systemic hypotension was associated with double the risk of 
death (Chesnut et al. 1993; Bratton et al. 2007). This observation serves to demonstrate that 
good basic critical care is paramount. Current guidelines recommend a systolic blood 
pressure greater than 90 mmHg as a resuscitation end-point (Bratton et al. 2007). Adequate 
fluid resuscitation is important, but vasopressors should be used if fluids are insufficient to 
maintain adequate systemic blood pressures. Intubation and mechanical ventilation are 
necessary for patients presenting with severe brain injuries in order to ensure adequate 
oxygenation and ventilation, and to minimize the risk of aspiration (Valadka & Robertson 
2007). Admission to a dedicated neuroscience critical care unit, when available, may also 
result in improved outcomes (Patel et al. 2005). 
Ventilator management in patients with severe TBI presents some unique challenges 
because of the effect of PaCO2 on cerebrovascular autoregulation. Hyperventilation has long 
been recognized as an effective means for treating acutely elevated intracranial pressure. 
Hyperventilation results in a systemic respiratory alkalosis, which in turn lowers the pH of 
the cerebrospinal fluid. In patients with intact cerebral autoregulation, this change in pH 
results in constriction of cerebral arterioles, thereby decreasing the cerebral blood volume 
and lowering the intracranial pressure. As a result of this phenomenon, routine 
hyperventilation of TBI patients has been advocated in the past. However, experimental 
evidence has demonstrated that the vasoconstrictive effect is relatively short-lived, 
(Muizelaar et al. 1988) and there is concern that continued hyperventilation could potentiate 
cerebral ischemia (Bratton et al. 2007). Furthermore, subsequent efforts to correct an 
iatrogenic respiratory alkalosis sometimes precipitate rebound increases in intracranial 
pressure (Valadka & Robertson 2007). For these reasons, hyperventilation is usually 
employed only as a temporizing measure in patients suffering an acute neurological decline.  
The relationship between PaCO2 and cerebral blood flow becomes particularly problematic 
in TBI patients with co-morbid lung injury. Acute lung injury (ALI) and acute respiratory 
distress syndrome (ARDS) are not uncommon in the neurological critical care unit. Since the 
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publication of the ARDSnet trial in 2000, the mainstay of therapy for patients with ALI and 
ARDS has been lung-protective ventilation, which minimizes barotrauma to the lungs by 
employing lower tidal volumes ( The Acute Respiratory Distress Syndrome Network 2000). 
This strategy results in a moderate degree of hypercapnea and hypoxemia. While lung-
protective ventilation significantly improved mortality in the study population, the relative 
hypercarbia and hypoxemia may have deleterious effects in a patient who is at risk for 
cerebral edema, ischemia, or vasospasm. Randomized trials in TBI patients with ARDS are 
lacking. Monitoring of cerebral perfusion and oxygenation, which is discussed in 
subsequent sections, is particularly crucial in this scenario (Young et al. 2010). 
Because of the brain’s role in regulating metabolism, patients with severe traumatic brain 
injury demonstrate a number of metabolic derangements which ultimately result in systemic 
catabolism (Cook, Peppard, & Magnuson 2008). Adequate nutritional support is essential to 
forestall adverse consequences, including protein loss and immunocompromise (Sacks et al. 
1995). Early institution of nutritional support has a significant impact on mortality and 
decreases the rate of hospital-acquired infections (Hartl et al. 2008; Taylor et al. 1999). 
Patients with severe TBI will require replacement of approximately 140% of their resting 
energy expenditure, though this requirement will be decreased somewhat in the setting of 
pharmacological paralysis or deep sedation. Protein requirements are estimated at about 
1.5-2 grams/kg of protein (Cook, Peppard, & Magnuson 2008). Close monitoring is essential 
to ensure adequate supplementation and avoid complications such as hyperglycemia. Early 
hyperglycemia has been associated with poor outcome in TBI patients (Liu-DeRyke et al. 
2009), but intensive glycemic control may exacerbate metabolic stress in some patients 
(Vespa et al. 2006). Although the optimal glucose range for TBI patients has yet to be 
determined, our institution has chosen 140-180 mg/dL as a reasonable target range. 
Because of their increased sympathetic tone, severity of illness, and degree of immobility, 
TBI patients are at high risk of complications of critical illness including infection and 
thromboembolism. Long-term use of prophylactic antibiotics is discouraged, though there is 
some evidence that brief treatment at the time of endotracheal intubation reduces the 
incidence of ventilator-associated pneumonia (Sirvent et al. 1997). Fevers are common in 
patients with traumatic brain injury, and may represent an underlying infection, 
hypothalamic dysfunction, or other non-infectious cause. Hyperpyrexia must be 
investigated exhaustively in order to rule out the possibility of an infectious etiology; 
however, any fever in a patient with neurological injury must be treated aggressively. 
Increased temperature results in increased cerebral blood flow, which can exacerbate 
intracranial hypertension and reduce intracranial compliance (Segatore 1992). Furthermore, 
animal studies have indicated that hyperthermia can increase infarct size and potentiate 
cellular damage (Dietrich et al. 1996; Dietrich & Bramlett 2007). For these reasons, aggressive 
treatment of fever in brain-injured patients is warranted. First-line treatments generally 
include antipyretics such as acetaminophen; cooling blankets, fans, and chilled fluids have 
also been employed (Johnston et al. 2006). Control of shivering is also important, as 
shivering can increase metabolic demand and impede efforts to maintain normothermia 
(Badjatia, Strongilis et al. 2008).  
Prevention of thromboembolic events is a major consideration in patients with severe TBI, 
especially in poly-trauma patients. Mechanical prophylaxis with graduated compression 
stockings and/or pneumatic compression devices is recommended, though these 
interventions may be contraindicated in the presence of significant injury to the lower 
extremities (Bratton et al. 2007). Pharmacological prophylaxis with unfractionated (UH) or 
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low-molecular weight heparin (LMWH) has been the subject of some debate. There is 
concern that use of pharmacological interventions could result in exacerbation of cerebral 
contusions, intracranial hemorrhage, and systemic bleeding. Evidence in a neurosurgical 
population indicates that pharmacological prophylaxis used in conjunction with mechanical 
devices is more effective than mechanical measures alone (Nurmohamed et al. 1996; Agnelli 
et al. 1998). Recent observational evidence suggests that initiation of prophylactic treatment 
with LMWH within 48 hours of injury or neurosurgical intervention is effective and 
associated with an acceptably low risk of complications (Norwood et al. 2008; Dudley et al. 
2010). Unfortunately, the most effective agent and dosing strategy is yet to be determined.  
5.2 Cerebral edema, intracranial hypertension and cerebral perfusion pressure 
The components of the intracranial compartment under normal circumstances consist of 
brain tissue, cerebrospinal fluid, and blood. Because the intracranial contents are contained 
within the rigid confines of the skull, any increase in volume—in the form of cerebral edema 
or a pathological mass lesion—must be met with a compensatory decrease in one of the 
other components, or the ICP will rise. Elevated ICP can result in cerebral ischemia, an 
important cause of secondary brain injury, by reducing cerebral perfusion pressure (CPP):  
CPP = MAP – ICP 
Where MAP is the mean arterial pressure.  
There is a considerable amount of debate regarding the relative importance of CPP and ICP 
thresholds. On one hand, observational data indicates that ICP > 20 mmHg is an 
independent predictor of morbidity and mortality (Helmy, Vizcaychipi, & Gupta 2007; 
Valadka & Robertson 2007; Robertson et al. 1999; Hiler et al. 2006; Czosnyka et al. 2005); 
however, good outcomes are possible even in the setting of exceptionally high ICPs, 
provided that cerebral perfusion is maintained. As a consequence, some centers advocate a 
CPP guided strategy, where as other clinical protocols focus predominantly on ICP and 
minimization of cerebral edema (Eker et al. 1998). Guidelines recommend ICP monitoring in 
patients with a Glasgow Coma Score (GCS) ≤ 8 who have abnormalities visible on computed 
tomography (CT). In the absence of CT abnormalities, ICP monitoring is indicated in 
comatose patients meeting 2 of the following criteria: age > 40 years, presence of motor 
posturing on exam, and/or SBP < 90 mmHg(Bratton et al. 2007). ICP values in excess of 20 
mmHg are considered pathological, though it is important to note that herniation can occur 
at lower ICPs, especially in the presence of intracranial mass lesions (Bratton et al. 2007). 
The situation is complicated by the fact that the relationship between ICP and CPP is 
affected by the integrity of cerebrovascular autoregulatory mechanisms. When cerebral 
autoregulation is intact, a fall in CPP is met with reflex cerebral vasodilation. This can 
precipitate an increase in ICP, thereby further diminishing cerebral perfusion (Robertson 
2001). In this setting, efforts to augment CPP artificially may abort a destructive cycle and 
arrest ongoing secondary brain injury. However, if CPP falls outside of the range of normal 
autoregulation, or if cerebral autoregulation is impaired, this relationship is reversed: ICP 
will rise in a linear fashion with increasing CPP, and artificial augmentation of cerebral 
blood flow may result in worsening cerebral edema and hyperemia. Initially, observational 
data using historical controls lead to the conclusion that CPP should be maintained at > 70 
mmHg. However, in a retrospective analysis of the Selfotel trial, Juul et al. found that there 
was no outcome benefit obtained by maintaining CPP > 60; interestingly, ICP ≥ 20 was the 
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most powerful predictor of outcome (Juul et al. 2000). The only randomized trial to date 
addressing the question of CPP vs. ICP was published by Robertson, et al. in 1999. In this 
trial, the CPP in one group was maintained at > 70 mmHg; in the other group, the ICP was 
maintained at ≤ 20 mmHg and CPPs as low as 50 mmHg were permitted. The investigators 
found no significant difference in outcome, but the CPP-targeted strategy carried five times 
the risk of ARDS (Robertson et al. 1999). An increasing appreciation of the role of 
cerebrovascular autoregulation in secondary brain injury has led some investigators to 
incorporate assessment of autoregulatory function into clinical protocols. The most readily 
available measure is the pressure reactivity index (PRx), which is a moving correlation 
coefficient calculated from measurements of ICP and MAP (Czosnyka et al. 1998). Centers 
that employ this measurement have reported that patients with intact autoregulation (PRx is 
low) have improved outcomes when managed according to a CPP guided paradigm, 
whereas those with impaired autoregulation (PRx is elevated) benefit from an ICP targeted 
strategy (Howells et al. 2005). Clearly, this observation warrants additional study. 
Interventions to control intracranial hypertension generally act to decrease the volume of one 
component of the intracranial compartment: blood, brain, or CSF. First line interventions 
include patient positioning, adequate sedation and analgesia, and maintenance of 
normothermia. The head of the bed should be elevated and any obstructions to jugular venous 
outflow, such as cervical collars, should be minimized. Adequate sedation and analgesia serve 
to minimize ventilator dyssynchrony, lower intrathoracic and intraabdominal pressure, and 
decrease agitation (Helmy, Vizcaychipi, & Gupta 2007). Treating systemic fever can mitigate 
the associated CNS hyperemia prevent shivering and rigors, which often result in increased 
ICP. If an external ventricular drain is present, diversion of cerebrospinal fluid can be helpful 
as well.  
Use of hyperosmolar substances is the mainstay of therapy for cerebral edema, with or 
without associated intracranial hypertension (Bhardwaj 2007). Infusion of a hyperosmolar 
substance serves to generate an osmotic gradient across the blood-brain-barrier, which 
reduces cerebral edema by drawing water out of the brain tissue. Mannitol and hypertonic 
saline (HTS) are the most commonly used agents in clinical practice. Mannitol is generally 
given as a bolus in doses ranging from 0.25-1.5 grams/kg. Hypertonic saline can be 
administered as a bolus or as a continuous infusion. For continuous use, concentrations 
ranging from 2% to 7.5% have been reported; boluses of 23.4% NaCl can be used in the 
setting of acute neurological decline. Use of either agent can result in rapid improvement in 
ICP; therefore, selection of the appropriate treatment will depend upon the clinical scenario. 
Mannitol can easily be infused through a peripheral intravenous line, whereas 
concentrations of HTS > 2% require central access. Mannitol acts as an osmotic diuretic, and 
can result in intravascular volume depletion, hypokalemia, and hypotension. There is 
concern that repeated dosing can result in renal impairment, especially if the drug is not 
adequately cleared by the kidneys; this can be monitored by calculating the osmolal gap. 
Hypertonic saline, on the other hand, acts as a volume expander and has been shown to be 
an effective means of reducing ICP even in patients who did not respond to mannitol 
(Ogden, Mayer, & E. Sander Connolly 2005; Vialet et al. 2003; Schwarz et al. 2002). Potential 
adverse events include congestive heart failure and hyperoncotic hemolysis; rapid 
administration of concentrated solutions may also result in transient hypotension. Either 
agent has the potential to accumulate in brain tissue in the presence of disruption of the 
blood-brain-barrier, Also, continued exposure to a hypertonic environment induces the 
generation of idiogenic osmoles within brain tissue, possibly setting the stage for rebound 
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intracranial hypertension when the serum osmolarity begins to fall (Diringer & Zazulia 
2004). Consequently, close monitoring of the patients’ ICP, CPP, serum sodium, and serum 
osmolarity is required. Despite the lack of convincing evidence, general consensus it that 
driving the serum sodium above 160 mEq/L is rarely beneficial, and most clinicians try to 
maintain the serum osmolarity below 320 mOsm/L (Hays et al. 2011).  
When intracranial hypertension persists despite maximal osmotherapy, ICP may be 
controlled by interventions designed to decrease the cerebral blood volume. This can be 
accomplished by suppressing brain metabolism, either by inducing a pharmacological coma 
or with therapeutic hypothermia. Induction of a pharmacological coma is usually 
accomplished using barbiturates, such as pentobarbital. Barbiturates have been shown 
experimentally to mitigate the development of brain edema (Mishina & Yabuki 1994), 
decrease cerebral metabolism, and lower cerebral blood flow (Kassell, Hitchon et al. 1980). 
Early experimental data suggested a neuroprotective effect in models of focal cerebral 
ischemia (Smith et al. 1974); however, subsequent small-scale clinical trials were 
disappointing (Ward et al. 1985; Kassell, Peerless et al. 1980). Studies in brain injured 
patients indicate that barbiturates may be less effective than mannitol as an initial 
intervention, but nevertheless are useful in patients who have failed maximal osmotherapy 
(Eisenberg et al. 1988; Schwartz et al. 1984; Marshall et al. 2010). Pentobarbital has a number 
of undesireable side-effects including systemic hypotension, decreased gastric motility, and 
bone marrow suppression (Meyer et al. 2010). In addition, continuous infusion of 
pentobarbital results in delayed drug clearance, which can delay detection of neurological 
improvement or decline. Continuous electroencephalography allows the clinician to titrate 
to burst-suppression, thereby ensuring that the minimum effective dose is employed. 
Several other agents, including propofol and midazolam, can be used to suppress CNS 
metabolism and induce burst-suppression, though they do not appear to be as effective as 
barbiturates in the treatment of intracranial hypertension (Meyer et al. 2010; Stewart et al. 
1994). Unfortunately, no comparative trials are available. 
Induced hypothermia has been investigated as a neuroprotective strategy in many disease 
states, and is currently the standard of care for comatose patients following cardiac arrest 
(Bernard & Buist 2003; Mild therapeutic hypothermia to improve the neurologic outcome 
after cardiac arrest 2002; Bernard et al. 2002). Moderate hypothermia has been shown to 
decrease the cerebral metabolic rate considerably (Rosomoff & Holaday 1954). In models of 
ischemia, it serves to decrease the concentrations of lactate and excitotoxic neurotransmitters 
(Illievich et al. 1994). Although clinical trials have failed to demonstrate an outcome benefit 
for early hypothermia in traumatic brain injury (Clifton et al. 2001), there is ample evidence 
that moderate hypothermia is an effective intervention for intracranial hypertension (Meyer 
et al. 2010). Most investigators used a target temperature between 33-35oC, which can be 
achieved using a variety of cooling methods (Marion et al. 1993; Marion et al. 1997; Liu et al. 
2006; Qiu et al. 2007; Jiang, Yu, & Zhu 2000; Shiozaki et al. 1993). Complications of moderate 
hypothermia include an increased susceptibility to infection, cardiac arrhythmias, 
coagulopathy, and electrolyte disturbances. Iatrogenic hypothermia can also mask a fever, 
and potentially delay the diagnosis of an underlying infection; for that reason, the authors 
advocate following the white blood cell count and obtaining periodic cultures in all 
hypothermic patients. Shivering is often encountered during the induction and rewarming 
phases, and this can counteract the beneficial effects of hypothermia on ICP and cerebral 
metabolic rate. Pharmacological paralysis is often used to prevent shivering, but other 
interventions including magnesium, dexmedetomidine, and meperidine have also been 
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used successfully (Weant et al. 2010). Many of these complications of systemic hypothermia 
may be mitigated by the use of selective brain cooling devices, which are employed at some 
institutions (Qiu et al. 2006; Liu et al. 2006). 
The duration of hypothermia therapy can vary widely depending upon the clinical needs of 
the individual patient; reports in the literature range from 24 hours to 14 days (McIntyre et 
al. 2003). The rewarming phase of therapy is critical due to the risk of mitochondrial injury, 
vascular dysregulation, and rebound increases in ICP (Jiang, Yu, & Zhu 2000; Jiang & Yang 
2007; Povlishock & Wei 2009). Although the optimum rewarming rate has yet to be 
determined, most authors advocate rates of approximately 0.5-1o/hour (Bernard & Buist 
2003; Bernard et al. 2002; Alzaga, Cerdan, & Varon 2006). At our institution, cooling is 
generally performed for a minimum of 48 hours. If the patient’s ICP remains well-controlled 
during that period, rewarming is initiated at a rate of approximately 0.50/hr. In the event of 
recurrent intracranial hypertension, rewarming is halted for an additional 12-24 hours 
before repeating the attempt.  
5.3 Advanced neuromonitoring 
In an effort to elucidate the mechanisms of secondary brain injury in severe TBI and 
improve outcomes from this highly morbid condition, a number of technologies have been 
developed to provide information regarding brain function, oxygenation, and perfusion. 
Neurophysiologic techniques such as electroencephalography have been used intermittently 
in brain injured patients for decades; however, recent evidence suggests that continuous 
monitoring may provide considerable benefit. Similarly, recent technological advances have 
enabled the bedside assessment of cerebral perfusion and oxygenation at the bedside. These 
techniques will be discussed briefly in the following sections. 
5.3.1 Continuous electroencephalography 
Electroencephalography (EEG) is used for a variety of indications in brain injured 
patients. Continuous electroencephalography (cEEG) can be employed for the diagnosis 
and treatment of seizures, in order to titrate barbiturate therapy, as an indicator of 
cerebral ischemia, and to provide information regarding prognosis. Seizures are a well 
known complication of TBI, and can contribute to ongoing secondary brain injury 
(Claassen et al. 2004; Vespa et al. 1999). The incidence of electrographic seizures in 
severely head injured patients has been reported at 22-33%, with more than half of these 
events being clinically silent (Vespa et al. 1999; Ronne-Engstrom & Winkler 2006). 
Moreover, investigators utilizing intracortical electroencephalography report recording 
several seizures which were occult on simultaneous scalp EEG (Waziri et al. 2009). 
Seizures are both more likely and more difficult to detect in comatose patients, suggesting 
that these patients are most likely to benefit from continuous EEG (cEEG) monitoring 
(Claassen et al. 2004). Early post-traumatic seizures have been associated with adverse 
physiological events, including elevation of intracranial pressure and an increase in the 
lactate to pyruvate ratio (Vespa et al. 2007). There is no clear association between isolated 
post-traumatic seizures and increased mortality; however, case series suggest that post-
traumatic status epilepticus carries a high risk of death (Vespa et al. 1999; Bratton et al. 
2007). Although most investigators advocate treatment of early post-traumatic seizures as 
a means for reducing secondary brain injury, it remains to be determined if this 
intervention improves patient outcome. 
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5.3.2 Cerebral blood flow and brain tissue oxygenation 
The recognition of cerebral ischemia as a major contributing factor to secondary brain injury 
has generated considerable interest in measurement of cerebral perfusion in head injured 
patients. A number of imaging techniques, including transcranial Doppler ultrasound, 
xenon-enhanced CT, CT perfusion imaging, perfusion weighted MRI, and positron emitted 
tomography are available to evaluate cerebral perfusion. Using these techniques, 
investigators have demonstrated that cerebral blood flow following head trauma follows 
three distinct hemodynamic phases: initial hypoperfusion, accompanied by reduced cerebral 
metabolic rate of oxygen (CMRO2); subsequent hyperemia, without an associated increase in 
CMRO2, which may be associated with intracranial hypertension; followed by a period in 
which cerebral blood flow (CBF) may be reduced secondary to vasospasm (Martin et al. 
1997). However, the physiological and pathophysiological significance of these phases has 
been debated, and significant regional variation of cerebral perfusion is present 
(Wintermark et al. 2004). As discussed previously, cerebral perfusion can be significantly 
affected by systemic factors that impact the MAP and the CPP; the magnitude of this effect 
is dependent upon the individual’s autoregulatory status (Czosnyka et al. 1998; Howells et 
al. 2005). Furthermore, the reports of the incidence and significance of cerebral vasospasm 
after trauma are variable, and likely are affected by the mechanism of injury (Martin et al. 
1997; Zubkov et al. 2000). MR, CT, and PET based imaging techniques provide information 
regarding cerebral perfusion over large regions of the brain parenchyma, but for the most 
part the data obtained is useful only for a single time point. Transcranial Doppler can be 
performed for extended periods of time, but it is limited to the evaluation of the large 
vessels surrounding the Circle of Willis, and image quality is highly operator-dependent. 
More recently, parenchymal monitors have been used to provide a continuous measurement 
of cerebral blood flow in a specific, small region of tissue using thermal diffusion. This device 
is placed in the perilesional white matter via a burr hole in the skull. Use of CBF monitoring is 
currently employed in some centers and may provide a method for continuous assessment of 
cerebrovascular autoregulation in the future (Rosenthal et al. 2011).  
In addition to CBF, brain oxygenation is often used as an indicator of cerebral ischemia. For 
decades, brain oxygenation could be assessed only indirectly, by intermittent sampling of 
the jugular venous blood. However, in the 1990s, a fiber-optic catheter which permitted 
continuous assessment of jugular venous oxygen saturation (SjvO2) became available (Ritter 
et al. 1996). SjvO2 provides a global measure of cerebral oxygenation and can permit early 
detection of cerebral ischemia. Studies have shown that jugular venous desaturations (< 
50%) are correlated with poor outcome, especially if prolonged and/or recurrent (Gopinath 
et al. 1994). However, cerebral metabolism in TBI demonstrates regional heterogeneity, and 
a global measure such as SjvO2 may not permit detection of focal regions of ischemia 
(Valadka et al. 2000). More recently, intraparenchymal monitors have become available for 
the purpose of monitoring local brain tissue oxygen tension (PbrO2). These monitors are 
typically inserted in normal-appearing brain tissue adjacent to a focal lesion, or in the right 
frontal region in the setting of diffuse axonal injury. As with SjvO2 monitoring, episodes of 
desaturation detected by PbrO2 monitoring have been shown to correlate with increased 
mortality (Stiefel et al. 2005). The critical value appears to be approximately 15 mmHg, 
though some clinicians prefer a treatment threshold of 20 mmHg (Bratton et al. 2007). 
Various investigators have studied the relationships between PbrO2 and more conventional 
clinical parameters. In particular, positive correlations have been described between PbrO2 
and various determinants of oxygen supply to the CNS, including FiO2, PaO2, CPP, and 
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hemoglobin concentration (Stiefel et al. 2005). However, studies using PET imaging and 
monitoring of the arteriovenous oxygen tension difference have provided evidence that 
barriers to local oxygen diffusion, rather than determinants of oxygen supply, are significant 
determinants of PbrO2 (Rosenthal et al. 2008; Bratton et al. 2007). 
A drop in cerebral oxygenation (as measured by PbrO2 or SjvO2) should prompt an 
investigation for an underlying cause, such subclinical seizures; an expanding mass lesion; 
suboptimal CPP; or systemic derangements such as hypotension or worsening lung 
function. The two monitoring methods are often complementary. For instance, PbrO2 is 
more sensitive to changes in the arterial oxygen content, and would be more likely to signal 
the expansion of a nearby contusion (Valadka et al. 2000). Cerebral oxygen desaturation can 
be successfully treated using measures designed to augment oxygen delivery, such as 
optimizing the CPP, increasing the fraction of inspired oxygen (FiO2), and transfusion of red 
blood cells depending upon the patient’s specific clinical characteristics; however, these 
interventions carry some risk. Normobaric hyperoxia has been shown to improve PbrO2 as 
well as some other markers of brain metabolism, but prolonged use exposes the patient to 
the risk of oxygen toxicity (Tisdall et al. 2008). Similarly, the optimal transfusion threshold 
for brain injured patients has yet to be determined, and injudicious use of blood products 
carries the risk of transfusion related lung injury, as well as other potential complications. A 
recent trial of 70 patients reported that a group of patients with severe TBI who received 
PbrO2 guided therapy (goal > 20 mmHg) demonstrated improved mortality and better 
functional outcomes than those managed using traditional ICP (< 20 mmHg) and CPP goals 
(> 60 mmHg)(Spiotta et al. 2010). However, this trial relied on historical controls, and the 
authors did not report on the incidence of ARDS or other medical complications in either 
cohort. A multicenter randomized controlled trial addressing the use of PbrO2 monitoring in 
severe TBI is currently underway.   
6. Surgical management 
Surgical intervention is indicated in TBI for control of intracranial hypertension or restoring 
integrity of structures covering the brain as in compound injuries. High ICP, following TBI, 
can result from a focal intracranial hematoma or diffuse brain swelling. “Moderate” sized 
contusion hematomas can present the surgeon with a dilemma about whether to operate or 
observe the patient. Presence of alcohol or drugs on board can further compound the 
situation. Close clinical observation, ICP monitoring, and a follow-up head CT scan can help 
to guide the therapy, but ultimately surgeon’s experience and clinical judgment plays a 
crucial role in decision making. 
Evidence based guidelines are available to help with decision-making (Bullock et al. 2006, 
2006; Bullock et al. 2006, 2006, 2006). Any mass lesion with progressive neurological decline 
referable to the lesion should be operated upon. A supratentorial lesion with a midline shift 
of 5 mm or more and effacement of the basal cisterns, and a posterior fossa lesion with 
compression or distortion of fourth ventricle or effacement of basal cisterns or obstructive 
hydrocephalus in patients with GCS of 8 or less should be evacuated. Epidural hematomas 
(EDH) larger than 30 cm3 and subdural hematomas greater than 10mm in thickness or 
causing more than 5 mm of midline shift should be evacuated, independent of the GCS. An 
EDH less than 30 cm3, and less than 15mm in maximal thickness, and with less than 5 mm 
midline shift, in a patient with a GCS of 9 or more without a focal deficit, can be managed 
non-surgically with close monitoring and repeat CT scans. Frontal or temporal lobe 
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contusions greater than 20 cm3 associated with midline shift of 5 mm or more, in patients 
with GCS of 6 to 8 or any parenchymal lesion greater than 50 cm3 should be operated upon. 
An open (compound) cranial fracture depressed greater than the thickness of cranium 
should be operated upon to prevent infection. An open (compound) depressed fracture may 
be treated non surgically if it is not depressed more than 1 cm, there is no dural penetration, 
no intracranial mass lesion, no frontal sinus involvement, no pneumocephalus, no cosmetic 
deformity, and no wound contamination or infection. 
Decompressive craniectomy (DC) is being increasingly used for patients with severe  
diffuse TBI and medically refractory intracranial hypertension (Ahmad & Bullock 2011).  
DC is effective in reducing the ICP and increasing the survival, but has not been shown  
to improve long term neurological outcome(Li, Timofeev et al. 2010). In fact, there is strong 
evidence to suggest that DC in patients with severe TBI (GCS 3-8) with medically refractory 
intracranial hypertension is associated with a worse neurological outcome at 6 months  
after injury compared to similar patients who were treated with controlled ventilation, 
mannitol, hypertonic saline, external ventricular drainage, mild hypothermia  
and barbiturates(Cooper et al. 2011). DC for treatment of medically refractory intracranial 
hypertension, in severe diffuse TBI, is discouraged till parameters other than ICP control 
are available, to gauge the success of therapy (Marion 2011).This procedure can still  
be an effective therapy in very select group of patients such as those undergoing 
craniotomy for intracranial hematoma (particularly SDH) with significant brain swelling. 
Unwarranted use of DC may prove counterproductive in terms of neurological recovery 
in patients with severe TBI. 
7. Future directions 
7.1 Microdialysis 
Microdialysis is an invasive monitoring technique which allows sampling of the 
extracellular fluid within the brain parenchyma in order to test for a variety of substances. 
Although a wide variety of substances can be analyzed successfully, glucose, lactate, 
pyruvate, glycerol, and glutamate are the most commonly employed. Glycerol is monitored 
primarily as a marker of membrane breakdown, whereas glucose, lactate, pyruvate, and the 
lactate/pyruvate ratio are used as markers of cerebral energy metabolism. The 
lactate/pyruvate ratio, in particular, is often employed as an indicator of the brain redox 
state and an early sign of focal ischemia. Microdialysis probes are usually placed in the 
frontal white matter in patients with diffuse brain injury, or in the pericontusional tissue in 
patients with focal radiographic abnormalities (Bellander et al. 2004). Although cerebral 
microdialysis has been widely used in animal studies for more than 30 years, its use in 
clinical practice is limited primarily to large academic centers where it is generally used in 
conjunction with other monitoring devices to provide an early indicator of evolving 
secondary brain injury. For instance, in cases of cerebral ischemia, the lacate/pyruvate ratio 
increases markedly, whereas the glucose level declines to near zero. These findings have 
been shown to correlate with SjVO2 and PbrO2 measurements, as well as the oxygen 
extraction fraction as measured by PET (Robertson et al. 1995; Valadka et al. 1998; 
Hutchinson et al. 2002). When used in conjunction with CPP and ICP monitoring, 
microdialysis may have a role in early detection of focal (as opposed to global) pathological 
processes, such as vasospasm or expanding contusions (Valadka & Robertson 2007; 
Hillered, Vespa, & Hovda 2005). 
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The data acquired by centers that utilize microdialysis routinely provides considerable 
insight into the pathophysiology of secondary brain injury in this population. For instance, 
Vespa et al. have reported persistently low glucose levels in cerebral microdialysate in the 
first 50 hours following brain injury in patients with poor outcome, which was unrelated to 
cerebral ischemia (Vespa et al. 2003). This may reflect a disorder of energy metabolism 
related to ongoing brain injury in patients with severe TBI. Work from the same group has 
demonstrated that intensive insulin therapy, as practiced in many surgical ICUs, often 
results in evidence of metabolic stress in patients with TBI (Vespa et al. 2006). Investigators 
studying the relationship between CPP on cerebral glucose metabolism have noted 
significant increases in the lactate/pyruvate ratio at CPPs less than 50mmHg which were 
confined to perilesional tissue. This work would seem to support the contention that 
susceptibility to ischemic insult is greater in a region of “tissue at risk” adjacent to 
contused brain (Nordstrom et al. 2003). Data on hyperventilated patients have been 
conflicting, with some studies reporting no effect (Letarte et al. 1999). In contrast, another 
study demonstrated that increased glutamate and lactate/pyruvate ratio could be 
demonstrated in TBI patients hyperventilated within 36 hours of injury, though these 
changes were seen much less commonly at later time points (Marion et al. 2002). This 
observation reinforces the hypothesis that sustained hyperventilation is particularly 
detrimental in the early stages following TBI. 
Microdialysis data has also been used to investigate the physiological effects of various 
therapeutic interventions. Hyperbaric oxygen therapy has been shown to result in a 
reproducible decrease in lactate and lactate/pyruvate ratio, which was accompanied by 
improvements in cerebral blood flow, CMRO2, and ICP (Rockswold et al. 2010). Similarly, 
microdialysis has been used to investigate the effect of barbiturates and propofol on cerebral 
energy metabolism. Thiopental coma was shown to reduce lactate in a small number of TBI 
patients, suggesting reduced anaerobic metabolism (Goodman et al. 1996). In contrast, 
propofol was not shown to have any significant effect on lactate, pyruvate, or glucose 
concentrations even when titrated to burst suppression (Johnston et al. 2003). Although both 
studies involved small numbers of patients, this would seem to suggest that barbiturates are 
more effective for the prevention of secondary brain injury. 
7.2 Biomarkers 
One of the major goals of ongoing research in TBI is the identification of reliable biomarkers. 
The ideal biomarker would enable early diagnosis of underlying brain injury, provide an 
early indicator of secondary brain injury, and enable clinicians to monitor the patient’s 
response to therapy. Conceivably, use of a variety of biomarkers specific to different tissue 
types or mechanisms of injury may help to guide therapy and provide insight into ongoing 
pathophysiology. Over the past 40 years, a variety of candidate molecules have been 
evaluated in both clinical settings and in animal models. Perhaps the most widely studied is 
S100B, a calcium-binding protein that is found in astrocytes. S100B has a half-life of < 60 min 
in serum; consequently, elevated levels are unlikely to persist for more than 24 hours in the 
absence of severe TBI (Berger 2006).  This protein can be quantified in the serum and in the 
CSF; the peak serum levels appear to occur roughly 48 hours after the peak CSF 
concentration is reached (Petzold et al. 2003). Elevated levels of S100B have been shown to 
correlate with poor outcome, contusion volume, and (inversely) with certain quality of life 
measures (Raabe et al. 1998; Woertgen, Rothoerl, & Brawanski 2002). Unfortunately, the 
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time course of S100B release, the dynamics of transport across the blood-brain-barrier, and 
the patho- physiological implications of elevated S100B levels remain to be determined 
(Kleindienst et al. 2010). Other candidate biomarkers associated with outcome in TBI 
patients include neuron specific enlace, a cytoplasm protein found in neuronal tissue, and 
glial fibrillary acidic protein (GFAP), an intermediate filament protein found in astrocytes 
(Vos et al. 2004) GFAP, in particular, has been shown to correlate with CT findings and with 
outcome in trauma patients (Lumpkins et al. 2008; Nylen et al. 2006). Although no large 
scale studies are available, some investigators suggest that GFAP may prove to be more 
sensitive than neuron-specific enolase (NSE) or S100B, due to the lack of extracerebral 
sources (Honda et al. 2010). 
Whereas NSE, S100B, and GFAP are markers of cellular breakdown, certain other candidate 
biomarkers serve as indicators of ongoing pathophysiological processes. For instance, 
diffuse axonal injury is characterized pathologically by axonal degradation, which is 
associated with the breakdown of axonal microtubules. This results in the release of 
microtubule-associated protein tau, which is cleaved into fragments which are known as 
cleaved-tau (C-tau) (Li, Li et al. 2010). The presence of C-tau in the CSF has been found to be 
a sensitive indicator of diffuse axonal injury, and levels correlate inversely with clinical 
improvement (Zemlan et al. 1999).  Other putative biomarkers have the potential to allow 
investigators to differentiate between cell death related to apoptosis as opposed to necrosis. 
The alpha-II spectrin protein, for example, is a component of the axonal cytoskeleton which 
is cleaved by enzymes involved in both cellular necrosis (caspase-3) and apoptosis (calpain 1 
and 2). Western blot analysis of the alpha-II spectrin breakdown products present in a given 
sample can therefore provide insight into the predominant mechanism of cellular loss (Li, Li 
et al. 2010). Preliminary studies using alpha-II spectrin breakdown products in humans have 
demonstrated that necrosis, mediated by calpain, is the predominant mechanism involved 
in acute DAI, suggesting that calpain inhibitors may be a potential therapeutic target 
(Brophy et al. 2009).     
7.3 Pharmacotherapy 
A major factor contributing to intractable intracranial hypertension following severe TBI is 
cerebral edema. Both cytotoxic and vasogenic edema contribute to post traumatic cerebral 
edema (Barzo et al. 1997). Therapeutic interventions directed at mediators of cerebral edema 
offer potential treatment options for TBI. Aquaporins (AQPs) are integral membrane 
proteins that form pores in membranes of mammalian cells, and play an important role in 
development and resolution of cerebral edema (Pasantes-Morales & Cruz-Rangel 2010). 
AQPs modulation offers a potential therapeutic intervention to prevent or treat brain 
swelling (Manley et al. 2000; Papadopoulos & Verkman 2008; Taya et al. 2008). Matrix 
metalloproteinases (MMPs) are zinc dependent endopeptidases involved in the process of 
tissue remodeling following brain injury from stroke or trauma. MMPs are upregulated 
following TBI, causing disruption of BBB and cerebral edema in the early phase, followed by 
neurogenesis and neurovascular remodeling in the later stages of recovery. Thus selective 
therapeutic blocking of the detrimental effects in the early phase offers the possibility of 
preventing cerebral edema without disrupting the later reparative phase (Donkin & Vink 
2010). A group of neuropeptides released from sensory neurons have been implicated in 
neurogenic inflammation. Neurogenic inflammation that includes vasodilation, plasma 
extravasation and neuronal hypersensitivity, has been shown to play a role in the 
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development of post traumatic cerebral edema. Therapeutic inhibition of neurogenic 
inflammation offers another potential target to prevent cerebral edema after TBI (Donkin & 
Vink 2010). Progesterone is another agent with potential therapeutic role in the 
management of TBI. Progesterone receptors are distributed throughout the central 
nervous system, and the steroid has neuroprotective properties. Progesterone decreases 
brain edema, attenuates free radicals and reduces neuronal loss in TBI animal model. 
There is class II evidence to suggest it may improve neurologic outcome in patients with 
TBI (Junpeng, Huang, & Qin 2011). 
8. Conclusion 
TBI is a serious disorder with significant morbidity, mortality and economic implications. It 
is a dynamic process, and timely intervention can prevent progression of neurological 
decline. Foundation of acute care is built upon prompt resuscitation and transport from the 
site of accident to a tertiary care facility, appropriate imaging, and intensive monitoring 
focused on minimization and prevention of secondary damage. Considerable progress has 
been made in understanding the physiology of ICP and treatment of intracranial 
hypertension, but control of ICP does not always translate into good neurological outcome. 
Better understanding of pathophysiology, identification of newer parameters of brain 
function, and development of innovative therapeutic modalities is required to improve the 
outcome from TBI.  
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